Filters
Q4 2024: a visual guide to ASA rulings
FCA interviews influencers under caution
Subscription contracts under the DMCC Act
Financial services matters - December 2024
Beginner's guide to medicines advertising in Europe
Regulatory oversight in Europe strictly governs pharmaceutical advertising, including content, presentation, and audience, although with some variation between countries. Compliance with these regulations is essential to avoid sanctions and third-party damages claims.
2 of 4 Insights
National penalties for breach of medical device advertising rules
Penalties for breaching advertising laws for medical devices or IVDs in Europe include administrative fines, criminal fines, and damages for unfair competition, but with huge variation between countries. Compliance with local laws is crucial to avoid sanctions and third party damages claims.
3 of 4 Insights
Can medical devices be advertised on social media in Europe?
Advertising medical devices on social media in Europe is complex, requiring compliance with diverse national regulations and careful planning to avoid legal pitfalls.
1 of 4 Insights
Taking care around use of social media for medicines companies
Pharmaceutical companies must exercise caution when using social media for advertising in Europe. Compliance with diverse national laws, transparency in promotional activities, and careful planning are essential.
4 of 4 Insights
DEFRA user survey: share your feedback on the Nagoya Compliance Regulations 2015
